Ming-Kuei Jang
Directeur Général chez Aprinoia Therapeutics, Inc.
Profil
Ming-Kuei Jang is the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chief Executive Officer.
He is also the founder of Aprinoia Therapeutics, Inc. (founded in 2015) where he holds the title of Chairman & President-Asia Operations.
Currently, Dr. Jang is the Chief Scientific Officer at APRINOIA Therapeutics LLC.
In the past, he worked as an Associate Director at Glaxosmithkline China Ltd.
from 2010 to 2012.
Dr. Jang completed his undergraduate studies at National Taiwan University and obtained a doctorate degree from Boston University School of Medicine.
Postes actifs de Ming-Kuei Jang
| Sociétés | Poste | Début |
|---|---|---|
Aprinoia Therapeutics, Inc.
 Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan. | Directeur Général | 20/05/2015 |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Fondateur | 01/01/2015 |
| APRINOIA Therapeutics LLC | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Ming-Kuei Jang
| Sociétés | Poste | Fin |
|---|---|---|
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | 01/03/2012 |
Formation de Ming-Kuei Jang
| Boston University School of Medicine | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
| Entreprise privées | 3 |
|---|---|
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
| APRINOIA Therapeutics LLC | |
| Glaxosmithkline China Ltd. |
